Groupama Asset Managment Buys Shares of 11,427 Cardinal Health, Inc. (NYSE:CAH)

Groupama Asset Managment purchased a new position in shares of Cardinal Health, Inc. (NYSE:CAH) in the 4th quarter, according to the company in its most recent filing with the SEC. The fund purchased 11,427 shares of the company’s stock, valued at approximately $1,347,000.

A number of other institutional investors and hedge funds have also modified their holdings of the business. Public Sector Pension Investment Board raised its position in shares of Cardinal Health by 12.7% during the 3rd quarter. Public Sector Pension Investment Board now owns 10,637 shares of the company’s stock valued at $1,176,000 after acquiring an additional 1,200 shares during the last quarter. Kestra Investment Management LLC acquired a new stake in shares of Cardinal Health during the third quarter worth $202,000. Paloma Partners Management Co bought a new stake in Cardinal Health in the third quarter valued at about $283,000. Benjamin Edwards Inc. lifted its stake in Cardinal Health by 802.5% in the third quarter. Benjamin Edwards Inc. now owns 4,630 shares of the company’s stock valued at $512,000 after buying an additional 4,117 shares during the period. Finally, Centiva Capital LP acquired a new position in Cardinal Health in the third quarter valued at about $1,088,000. 87.17% of the stock is owned by institutional investors.

Cardinal Health Stock Up 1.2 %

NYSE:CAH opened at $138.82 on Thursday. Cardinal Health, Inc. has a twelve month low of $93.17 and a twelve month high of $139.15. The company has a market cap of $33.53 billion, a P/E ratio of 25.90, a price-to-earnings-growth ratio of 1.49 and a beta of 0.66. The business has a 50 day moving average price of $128.98 and a two-hundred day moving average price of $121.33.

Cardinal Health (NYSE:CAH) last released its earnings results on Thursday, January 30th. The company reported $1.93 earnings per share for the quarter, beating analysts’ consensus estimates of $1.74 by $0.19. Cardinal Health had a net margin of 0.59% and a negative return on equity of 59.57%. As a group, analysts anticipate that Cardinal Health, Inc. will post 7.95 earnings per share for the current fiscal year.

Cardinal Health Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Tuesday, April 15th. Investors of record on Tuesday, April 1st will be given a dividend of $0.5056 per share. The ex-dividend date of this dividend is Tuesday, April 1st. This represents a $2.02 annualized dividend and a yield of 1.46%. Cardinal Health’s dividend payout ratio (DPR) is presently 37.69%.

Analysts Set New Price Targets

A number of analysts have recently commented on CAH shares. JPMorgan Chase & Co. upped their price target on Cardinal Health from $142.00 to $145.00 and gave the company a “neutral” rating in a research note on Tuesday, February 4th. Citigroup upped their target price on shares of Cardinal Health from $120.00 to $129.00 and gave the company a “neutral” rating in a research note on Friday, January 10th. Evercore ISI upgraded shares of Cardinal Health from an “in-line” rating to an “outperform” rating and set a $140.00 target price on the stock in a report on Tuesday, January 7th. Argus set a $148.00 price target on shares of Cardinal Health in a report on Tuesday, February 4th. Finally, TD Cowen raised Cardinal Health from a “hold” rating to a “buy” rating and raised their price objective for the stock from $130.00 to $144.00 in a research note on Wednesday, January 8th. Four investment analysts have rated the stock with a hold rating and eleven have assigned a buy rating to the company. According to MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $140.14.

Cardinal Health Profile

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.